Skip to main content
Lipocine Inc. logo

Lipocine Inc. — Investor Relations & Filings

Ticker · LPCN ISIN · US53630X1046 LEI · 549300RXPEQXOJXVBI10 US Manufacturing
Open in API
Filings indexed 786 across all filing types
Latest filing 2017-08-08 Investor Presentation
Country US United States of America
Listing US LPCN

About Lipocine Inc.

https://www.lipocine.com/

Lipocine Inc. is a clinical-stage biopharmaceutical company that develops treatments for metabolic, endocrine, and central nervous system disorders. The company leverages its proprietary Lip'ral drug delivery technology to enhance the oral absorption of water-insoluble drugs, aiming to improve patient compliance and therapeutic outcomes. Its portfolio includes TLANDO®, an FDA-approved oral testosterone replacement therapy. Lipocine's development pipeline features candidates for conditions such as non-alcoholic steatohepatitis (NASH), postpartum depression, obesity, and prevention of preterm birth. The company's strategy often involves using the 505(b)(2) regulatory pathway to develop improved formulations of established drugs.

Recent filings

Filing Released Lang Actions
FORM 8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated August 8, 2017, by Lipocine Inc. It announces an update to the company's corporate presentation used for investor meetings, which is attached as Exhibit 99.1. The text does not contain financial statements or detailed financial analysis but rather an announcement of an updated presentation. The document length is 2733 characters, which is relatively short and consistent with an announcement rather than a full report. According to the classification rules, announcements of presentations for investors fall under Investor Presentation (IP). Therefore, the document is best classified as an Investor Presentation update.
2017-08-08 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and references a press release for the financial results of the quarter ended June 30, 2017. The document itself does not contain detailed financial statements or substantive financial data but rather refers to a press release filed as an exhibit. The length of the document is 2947 characters, which is relatively short and consistent with an announcement rather than a full financial report. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a current report announcing financial results but does not contain the full financial data itself, and it is not an earnings release (ER) since the actual financial results are in the press release exhibit, not in the main text. Therefore, the appropriate classification is Regulatory Filings (RNS).
2017-08-07 English
10-Q
Interim / Quarterly Report Q2 2017
2017-08-07 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate updates. The text specifically mentions an update to the company's corporate presentation used for investor meetings, filed as Exhibit 99.1. There is no detailed financial data or comprehensive report content included, only a notification of the updated presentation. The document length is short (2655 characters), and it serves as an announcement rather than the full presentation itself. According to the classification rules, such a document is best categorized as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit into more specific categories like Investor Presentation (IP) since the presentation is only referenced as an exhibit, not included in full.
2017-07-10 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is used for current reports about significant events. The text specifically mentions the termination of an executive officer, which falls under Item 5.02 related to departure of directors or certain officers. There are no financial statements or exhibits attached, and the document is relatively short (2656 characters). This type of filing is an announcement of management changes rather than a full management report or annual report. Therefore, it fits the category of Board/Management Information (MANG).
2017-07-07 English
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate updates. The text specifically mentions that the company has updated its corporate presentation used for investor meetings and that this presentation is filed as an exhibit. There are no financial statements or detailed financial data included in the text itself, only a reference to the presentation. The document length is short (2650 characters), and it primarily serves as an announcement of the updated investor presentation rather than the presentation content itself. According to the classification rules, such a document is best classified as an Investor Presentation (IP) since it relates to a detailed presentation for investors focusing on financials, strategy, and market position, and it is explicitly described as a corporate presentation for investors.
2017-06-28 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.